EpiVax
Providence
About EpiVax
EpiVax is an immunology company and has developed comprehensive analytical capabilities in the field of computational immunology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.6M
- Funding stage: Seed
- Last round: Grant (Sep 2022)
- Website: epivax.com
- Phone: 4012727562
Industries & Categories
Analytics, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/epivax-120286 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.